ResMed Inc. Stock price Australian S.E.

Equities

RMD

AU000000RMD6

Advanced Medical Equipment & Technology

Market Closed - Australian S.E. 01:10:10 2024-03-28 am EDT 5-day change 1st Jan Change
30.15 AUD +0.74% Intraday chart for ResMed Inc. +2.73% +18.51%
Sales 2024 * 4.64B 7.15B Sales 2025 * 4.95B 7.62B Capitalization 28.84B 44.46B
Net income 2024 * 977M 1.51B Net income 2025 * 1.16B 1.79B EV / Sales 2024 * 6.35 x
Net Debt 2024 * 636M 981M Net cash position 2025 * 203M 313M EV / Sales 2025 * 5.79 x
P/E ratio 2024 *
30 x
P/E ratio 2025 *
25.8 x
Employees 10,140
Yield 2024 *
1%
Yield 2025 *
1.07%
Free-Float 77.08%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.74%
1 week+2.73%
Current month+13.09%
1 month+7.95%
3 months+18.37%
6 months+25.10%
Current year+18.51%
More quotes
1 week
29.26
Extreme 29.26
30.21
1 month
26.64
Extreme 26.64
30.21
Current year
24.44
Extreme 24.44
30.21
1 year
21.14
Extreme 21.14
36.37
3 years
21.14
Extreme 21.14
40.79
5 years
13.56
Extreme 13.56
40.79
10 years
4.72
Extreme 4.72
40.79
More quotes
Managers TitleAgeSince
Chief Executive Officer 51 00-08-31
Founder 81 89-05-31
Director of Finance/CFO 51 -
Members of the board TitleAgeSince
Chief Executive Officer 51 00-08-31
Director/Board Member 76 04-12-31
Founder 81 89-05-31
More insiders
Date Price Change Volume
24-03-28 30.15 +0.74% 2 158 925
24-03-27 29.93 +1.98% 1,910,650
24-03-26 29.35 -1.08% 1,061,119
24-03-25 29.67 -0.13% 1,392,429
24-03-22 29.71 +1.23% 1,188,409

Delayed Quote Australian S.E., March 28, 2024 at 01:10 am EDT

More quotes
ResMed, Inc. specializes in designing, manufacturing and marketing respiratory disorders diagnosis, treatments and management (primarily sleep respiratory disorders). Net sales break down by family of products as follows: - medical devices (50.4%); - masks (37.9%); - software as a service (11.7%). At the end of June 2021, the group had 6 production sites located in the United States (2), Australia, China, Singapore and Malaysia. The United States accounts for 61.4% of net sales.
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
196.3 USD
Average target price
205 USD
Spread / Average Target
+4.40%
Consensus
  1. Stock
  2. Equities
  3. Stock ResMed, Inc.
  4. Stock ResMed Inc. - Australian S.E.